Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-14 Sale |
2024-06-18 9:39 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,900 | $280 | $532,000 | 15,850 (Direct) |
View |
| 2024-06-12 Sale |
2024-06-14 9:44 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
2,000 | $285 | $570,000 | 20,700 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-23 9:36 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,036 | $231.34 | $239,668 | 5,500 (Direct) |
View |
| 2024-05-14 Sale |
2024-05-16 9:53 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
22,489 | $212.88 | $4,787,404 | 489,685 (Indirect Direct) |
View |
| 2024-04-08 Sale |
2024-04-10 8:53 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
2,676 | $245.99 | $658,258 | 1,191,103 (Indirect Direct) |
View |
| 2024-04-08 Sale |
2024-04-10 8:50 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
26,270 | $246.19 | $6,467,491 | 1,047,531 (Indirect Direct) |
View |
| 2024-04-03 Sale |
2024-04-05 8:50 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
73,888 | $243.92 | $18,022,588 | 1,425,808 (Indirect Direct) |
View |
| 2024-04-03 Sale |
2024-04-05 8:50 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
73,730 | $243.93 | $17,984,804 | 1,612,789 (Indirect Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 8:47 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
11,000 | $257.48 | $2,832,335 | 25,298 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 8:44 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
32,489 | $252.85 | $8,214,998 | 22,410 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 8:41 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
32,489 | $252.97 | $8,218,630 | 12,110 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
4,000 | $235.5 | $942,000 | 42,067 (Direct) |
View |
| 2023-12-13 Purchase |
2023-12-14 6:10 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
101,792 | $221.2 | $22,516,577 | 1,793,403 (Indirect) |
View |
| 2023-12-12 Purchase |
2023-12-14 6:09 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
34,578 | $218.31 | $7,548,616 | 1,699,129 (Indirect) |
View |
| 2023-12-12 Sale |
2023-12-14 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,800 | $222.82 | $846,700 | 50,567 (Direct) |
View |
| 2023-12-04 Sale |
2023-12-06 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
2,800 | $221.89 | $621,294 | 122,731 (Indirect Direct) |
View |
| 2023-11-29 Sale |
2023-12-01 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
7,000 | $201.5 | $1,410,480 | 54,531 (Indirect Direct) |
View |
| 2023-11-21 Purchase |
2023-11-21 6:15 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
64,350 | $188.47 | $12,128,340 | 1,667,104 (Indirect) |
View |
| 2023-11-17 Purchase |
2023-11-21 6:14 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
67,079 | $178.11 | $11,947,280 | 1,607,668 (Indirect) |
View |
| 2023-11-14 Purchase |
2023-11-15 5:13 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
49,387 | $158.13 | $7,809,559 | 1,545,775 (Indirect) |
View |
| 2023-11-13 Purchase |
2023-11-15 5:12 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
107,499 | $146.99 | $15,801,021 | 1,500,227 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-14 Exercise |
2024-06-18 9:39 pm |
N/A 2032-02-24 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,900 | $0 | 15,850 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 9:39 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,900 | $87.09 | 15,850 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 9:44 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
2,000 | $0 | 20,700 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 9:44 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
2,000 | $87.92 | 20,700 (Direct) |
View |
| 2024-06-11 Gift |
2024-06-13 9:45 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
84,852 | $0 | 404,833 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 9:53 pm |
N/A 2024-06-27 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
22,489 | $0 | 489,685 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 9:53 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
12,489 | $105.08 | 489,685 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 9:53 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
10,000 | $100.45 | 489,685 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-10 8:53 pm |
N/A 2026-07-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
2,676 | $0 | 1,191,103 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-10 8:53 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
2,676 | $9.45 | 1,191,103 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-10 8:50 pm |
N/A 2026-07-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
26,270 | $0 | 1,047,531 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-10 8:50 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
26,270 | $9.45 | 1,047,531 (Direct) |
View |
| 2024-04-03 Exercise |
2024-04-05 8:50 pm |
N/A 2026-07-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
73,888 | $0 | 1,425,808 (Direct) |
View |
| 2024-04-03 Exercise |
2024-04-05 8:50 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
73,888 | $9.45 | 1,425,808 (Direct) |
View |
| 2024-04-03 Exercise |
2024-04-05 8:50 pm |
N/A 2026-07-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
73,730 | $0 | 1,612,789 (Direct) |
View |
| 2024-04-03 Exercise |
2024-04-05 8:50 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
73,730 | $9.45 | 1,612,789 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:47 pm |
N/A 2026-08-11 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
11,000 | $0 | 25,298 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:47 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
5,000 | $7.36 | 25,298 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:47 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
6,000 | $111.06 | 25,298 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:44 pm |
N/A 2026-07-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
32,489 | $0 | 22,410 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:44 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
12,489 | $105.08 | 22,410 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:44 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
10,000 | $9.45 | 22,410 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:44 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
10,000 | $100.45 | 22,410 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:41 pm |
N/A 2024-06-27 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
32,489 | $0 | 12,110 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:41 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
12,489 | $105.08 | 12,110 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 8:41 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
20,000 | $100.45 | 12,110 (Direct) |
View |
Ownership |
2024-03-21 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO |
0 | $0 | 31,103 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 6:04 pm |
N/A 2031-01-23 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer |
9,122 | $0 | 20,595 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 5:54 pm |
N/A 2031-01-23 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
14,504 | $0 | 1,129,043 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 5:50 pm |
N/A 2031-01-23 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,557 | $0 | 10,093 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 3:29 pm |
N/A 2031-01-23 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Howarth Alex G. Chief Financial Officer |
12,041 | $0 | 30,778 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 3:24 pm |
N/A 2031-01-23 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
9,122 | $0 | 27,343 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 3:24 pm |
N/A 2031-01-23 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO |
30,709 | $0 | 92,959 (Direct) |
View |
| 2024-01-16 Tax Withholding |
2024-01-18 1:52 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
949 | $243.92 | 14,582 (Direct) |
View |
| 2023-01-16 Tax Withholding |
2024-01-18 1:47 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
2,254 | $243.92 | 841,275 (Direct) |
View |
| 2024-01-16 Tax Withholding |
2024-01-18 1:46 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
1,546 | $243.92 | 1,108,753 (Direct) |
View |
| 2024-01-16 Tax Withholding |
2024-01-18 1:45 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
550 | $243.92 | 5,117 (Direct) |
View |
| 2024-01-16 Tax Withholding |
2024-01-18 1:39 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Howarth Alex G. Chief Financial Officer |
1,067 | $243.92 | 13,934 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:30 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
4,000 | $0 | 42,067 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
4,000 | $87.92 | 42,067 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-14 4:30 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,800 | $0 | 50,567 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-14 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,800 | $87.92 | 50,567 (Direct) |
View |
| 2023-01-30 Gift |
2023-12-11 7:25 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
3,557 | $0 | 2,045,018 (Indirect) |
View |
| 2023-12-07 Other |
2023-12-11 7:25 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
1,556,594 | $0 | 2,045,018 (Indirect) |
View |
| 2023-12-04 Exercise |
2023-12-06 4:30 pm |
N/A 2032-08-10 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
2,800 | $0 | 122,731 (Direct) |
View |
| 2023-12-04 Exercise |
2023-12-06 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
2,000 | $87.09 | 122,731 (Direct) |
View |
| 2023-12-04 Exercise |
2023-12-06 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
800 | $73.75 | 122,731 (Direct) |
View |
| 2023-11-29 Exercise |
2023-12-01 4:30 pm |
N/A 2032-08-10 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
7,000 | $0 | 54,531 (Direct) |
View |
| 2023-11-29 Exercise |
2023-12-01 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
7,000 | $73.75 | 54,531 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 5:02 pm |
N/A 2033-11-20 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer |
17,911 | $0 | 17,911 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-13 4:41 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO |
50,000 | $0 | 100,000 (Direct) |
View |